Nrf2 promotes progression of non-small cell lung cancer through activating autophagy
Open Access
- 2 May 2017
- journal article
- other
- Published by Taylor & Francis in Cell Cycle
- Vol. 16 (11) , 1053-1062
Abstract
The transcription factor, NFE2-related factor 2 (Nrf2) and autophagy have been implicated in the oxidative-stress response during tumor evolution. However, few studies focus on crosstalk between Nrf2 and autophagy in cancer progression of non-small cell lung cancer (NSCLC). Herein, we evaluated the effect of Nrf2 on autophagy in NSCLC and their role in development of NSCLC. Effect of Nrf2 on overal survival (OS) of NSCLC patients were evaluated. Cell biological behaviors in response to Nrf2 were evaluated by MTT, colony formation assay and flow cytometry. Effect of 3-MA (a classical inhibitor of autophagy) on 95D-Nrf2 cells was also analyzed using flow cytometry. After up/down-regulating Nrf2 in NSCLC cell lines, expression of autophagy-related proteins were evaluated with western blot analysis. The results revealed that Nrf2 was an independent prognositc factor negtively associated with OS of NSCLC patients. Elevated Nrf2 expression promotes NSCLC progression, enhancing the escape of tumor cells from apoptosis in vivo and in vitro. Double staining with Annexin V-APC and 7-AAD showed that the proportions of apoptotic cells in 95D-Nrf2 cells were gradually increased after the addition of 3-MA. Importently, Nrf2 induced autophagosome formation and enhanced autophagic activity, which subsequently inhibits NSCLC cell apoptosis. In conclusion, our present study demonstrates that Nrf2 promotes progression of non-small cell lung cancer through activating autophagy. It provides novel insights into Nrf2-mediated of cell proliferation in NSCLC and may facilitate therapeutic development against NSCLC.Keywords
This publication has 27 references indexed in Scilit:
- Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapyInternational Journal of Nanomedicine, 2016
- Cytoprotection “gone astray’’: Nrf2 and its role in cancerOncoTargets and Therapy, 2014
- Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinomaOncology Reports, 2013
- The transcription factor NF‐E2‐related Factor 2 (Nrf2): a protooncogene?The FASEB Journal, 2012
- NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivityFree Radical Biology and Medicine, 2012
- The dynamic nature of autophagy in cancerGenes & Development, 2011
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian CancerCancer Research, 2011
- Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapyMolecular Cancer, 2011
- Nrf2 Defends the Lung from Oxidative StressAntioxidants & Redox Signaling, 2006
- A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.2001